Connect with us

Announcements

Carlos Santana Debuts Mirayo by Santana Cannabis Products with Left Coast Ventures

Published

on

Carlos Santana Mirayo Cannabis Left Coast Ventures

Hispanic-American and award-winning guitarist and renowned cannabis champion Carlos Santana on Tuesday, October 6, announced his partnership with Left Coast Ventures to launch a Mirayo by Santana, a spiritual and well-being focused premium cannabis line that,

“leverage the power of ancient remedies and act as a guide for consumers on their path to discovering their divine light.”

The new line offers users superior flower products that take advantage of old remedies’ power and guide consumers to discover their divine light since they are motivated by Santana’s Latin heritage and devotion to spiritual wellness.

The GRAMMY award winner is among the most influential and feted musicians at present. Santana has built his musical life and spiritual nourishment on the discovery, determination, and self-actualization.

Mirayo consolidates Santana’s beliefs into an outdoor grown product that gives consumers a cannabis spiritual effect. Mirayo, a contraction of “mi Rayo,” which is Spanish for “my ray,” seeks to inspire users to “follow your light.”

Santana said, according to his experience, cannabis contains unique properties that boost creative expression and meditative reflection. He added that it could dissipate uncertainty to divulge the eternal gift of people’s uniqueness. He said he hopes to help individuals use cannabis to promote benevolent traits such as kindness and compassion.

In the past, Left Coast Ventures partnered with different legendary musicians to launch cannabis brands such as Marley Natural™ with Bob Marley estate and Privateer Holdings and Mind Your Head™ with Grateful Dead widely-known drummer Mickey Hart.

Left Coast Ventures CEO Brett Cummings said it is a privilege to work with a musical icon who embraces deep spirituality, self-discovery, and ancient heritage to create a brand. He expressed his excitement to partner with Santana to curate an exceptional product line that improves energy flow in the mind and body.

The Mirayo line will feature 7g jars of the whole flower and five packs of 0.5g pre-rolls in Radiance, Centered, and Symmetry strains.

Radiance is Sativa aimed at expanding a person’s energy outward, stimulating imaginative expression, and reaching for godlike wisdom. Centered is an Indica designed to nudge consumers to inner peace, surpass usual physical limits, and insightful stillness. Symmetry is a hybrid meant to harmonize both the outward and the inward, body and mind, to raise understanding.

Mirayo by Santana is found at dispensaries in Southern California and the Bay, with dispensaries owned by Latinx prioritized.

Denis is one of the most experienced researchers for reviews we have with years of experience in writing about CBD products. He will be one of the most viewed authors due to his own thrill in sharing what he is learning about cannabidiol and supplement use. With a goal of providing clarity within the budding CBD oil industry, Denis will be spending much of the year going through a catalogue of cannabis oil companies in the near future.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.